D-1083-2023 Class III Terminated
FDA drug recall D-1083-2023 was initiated by B. Braun Medical Inc. on August 2, 2023 and is designated Class III. Reason for recall: Labeling: Not Elsewhere Classified - the description, warnings, storage information and instructions for use are either missing or partially printed. The recall status is terminated (terminated July 7, 2025). Affected quantity: 43,812 bags.
Recall Details
- Product Type
- Drugs
- Report Date
- August 16, 2023
- Initiation Date
- August 2, 2023
- Termination Date
- July 7, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 43,812 bags
Product Description
0.9% Sodium Chloride Injection USP, 1000 mL Excel Plus Container, Rx only, B. Braun Medical Inc. Bethlehem, PA 18018, NDC 0264-5802-00
Reason for Recall
Labeling: Not Elsewhere Classified - the description, warnings, storage information and instructions for use are either missing or partially printed.
Distribution Pattern
United States
Code Information
Lot #: 0061852531, Exp 2/28/2025